A Collaborative Approach for "ReSeq-ing" Mycobacterium tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers - PubMed (original) (raw)
A Collaborative Approach for "ReSeq-ing" Mycobacterium tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers
Marco Schito et al. EBioMedicine. 2015.
No abstract available
Keywords: Database; Drug resistance; Sequencing; Tuberculosis.
Figures
Fig. 1
Landscape of current and planned tuberculosis drug and new drug regimen clinical trials. A representation of various TB trials that are in analysis (green bars), began prior to 2015 (light blue bars), initiated in 2015 (dark blue bars), and not yet started (yellow bars). Abbreviations: DDI, drug–drug interaction; DS, drug sensitive; MDR, multi-drug resistant; ped, pediatric; PK, pharmacokinetic. Drug abbreviations: CLR, clarithromycin; DEL, delamanid; EMB, ethambutol; INH, isoniazid; LEV, levofloxacin; LZD, linezolid; MXF, moxifloxacin; PRE, pretomanid; PZA, pyrazidamide.
Similar articles
- The "source" of drug-resistant TB outbreaks.
van Helden PD, Victor T, Warren RM. van Helden PD, et al. Science. 2006 Oct 20;314(5798):419-20. doi: 10.1126/science.314.5798.419c. Science. 2006. PMID: 17053131 No abstract available. - Drug-Susceptible and Multidrug-Resistant Mycobacterium tuberculosis in a Single Patient.
Baffoe-Bonnie A, Houpt ER, Turner L, Dodge D, Heysell SK. Baffoe-Bonnie A, et al. Emerg Infect Dis. 2019 Nov;25(11):2120-2121. doi: 10.3201/eid2511.180638. Epub 2019 Nov 17. Emerg Infect Dis. 2019. PMID: 31454310 Free PMC article. - [Mycobacterium tuberculosis with extensive resistance].
Labie D. Labie D. Med Sci (Paris). 2007 Feb;23(2):205-9. doi: 10.1051/medsci/2007232205. Med Sci (Paris). 2007. PMID: 17291432 Review. French. No abstract available. - Early Biomarkers and Regulatory Innovation in Multidrug-Resistant Tuberculosis.
Wallis RS, Peppard T. Wallis RS, et al. Clin Infect Dis. 2015 Oct 15;61Suppl 3:S160-3. doi: 10.1093/cid/civ612. Clin Infect Dis. 2015. PMID: 26409278 - [Molecular mechanisms of the formation of drug resistance of Mycobacterium tuberculosis (review of the literature)].
Tungusova OS, Mar'iandyshev AO. Tungusova OS, et al. Probl Tuberk. 2001;(6):48-9. Probl Tuberk. 2001. PMID: 11641963 Review. Russian. No abstract available.
Cited by
- Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase.
Ezewudo M, Borens A, Chiner-Oms Á, Miotto P, Chindelevitch L, Starks AM, Hanna D, Liwski R, Zignol M, Gilpin C, Niemann S, Kohl TA, Warren RM, Crook D, Gagneux S, Hoffner S, Rodrigues C, Comas I, Engelthaler DM, Alland D, Rigouts L, Lange C, Dheda K, Hasan R, McNerney R, Cirillo DM, Schito M, Rodwell TC, Posey J. Ezewudo M, et al. Sci Rep. 2018 Oct 18;8(1):15382. doi: 10.1038/s41598-018-33731-1. Sci Rep. 2018. PMID: 30337678 Free PMC article. - Mycobacterial biomaterials and resources for researchers.
Hazbón MH, Rigouts L, Schito M, Ezewudo M, Kudo T, Itoh T, Ohkuma M, Kiss K, Wu L, Ma J, Hamada M, Strong M, Salfinger M, Daley CL, Nick JA, Lee JS, Rastogi N, Couvin D, Hurtado-Ortiz R, Bizet C, Suresh A, Rodwell T, Albertini A, Lacourciere KA, Deheer-Graham A, Alexander S, Russell JE, Bradford R, Riojas MA. Hazbón MH, et al. Pathog Dis. 2018 Jun 1;76(4):fty042. doi: 10.1093/femspd/fty042. Pathog Dis. 2018. PMID: 29846561 Free PMC article. Review. - Identification and Characterization of Mycobacterial Species Using Whole-Genome Sequences.
Riojas MA, Frank AM, Greenfield SR, King SP, Meehan CJ, Strong M, Wattam AR, Hazbón MH. Riojas MA, et al. Methods Mol Biol. 2021;2314:399-457. doi: 10.1007/978-1-0716-1460-0_19. Methods Mol Biol. 2021. PMID: 34235665 - The Relative Positioning of Genotyping and Phenotyping for Tuberculosis Resistance Screening in Two EU National Reference Laboratories in 2023.
Anthony R, Groenheit R, Mansjö M, de Zwaan R, Werngren J. Anthony R, et al. Microorganisms. 2023 Jul 14;11(7):1809. doi: 10.3390/microorganisms11071809. Microorganisms. 2023. PMID: 37512981 Free PMC article. Review.
References
- Dye C., Glaziou P., Floyd K., Raviglione M. Prospects for tuberculosis elimination. Annu. Rev. Public Health. 2013;34:271–286. - PubMed
- Evangelopoulos D., McHugh T.D. Improving the tuberculosis drug development pipeline. Chem. Biol. Drug Des. 2015;(Mar 16) - PubMed
- Fenner L., Egger M., Bodmer T., Altpeter E., Zwahlen M., Jaton K., Pfyffer G.E., Borrell S., Dubuis O., Bruderer T., Siegrist H.H., Furrer H., Calmy A., Fehr J., Stalder J.M., Ninet B., Böttger E.C., Gagneux S., Swiss HIV Cohort Study and the Swiss Molecular Epidemiology of Tuberculosis Study Group Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2012;56:3047–3053. - PMC - PubMed
- Noor K.M., Shephard L., Bastian I. Molecular diagnostics for tuberculosis. Pathology. 2015;47:250–256. - PubMed
- Salamon H., Yamaguchi K.D., Cirillo D.M., Miotto P., Schito M., Posey J., Starks A.M., Niemann S., Alland D., Hanna D., Aviles E., Perkins M.D., Dolinger D.L. Integration of published information into a resistance-associated mutation database for Mycobacterium tuberculosis. J. Infect. Dis. Suppl. 2015;2:S50–S57. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources